Tardive dyskinesia in an adolescent

Area of Science:

• Child and Adolescent Psychiatry
• Neuroscience
• Pharmacology

Background:

• Neuroleptic medications are frequently prescribed for disturbed children and adolescents.
• Clinicians must be aware of the potential risk of tardive dyskinesia (TD) in this population.
• Tardive dyskinesia is a serious side effect characterized by involuntary movements.

Observation:

• A case of a 15-year-old male who developed severe, incapacitating tardive dyskinesia is presented.
• The patient's symptoms resolved with treatment using deanol.
• The case highlights the importance of recognizing and managing TD in pediatric patients.

Findings:

• Deanol demonstrated efficacy in resolving tardive dyskinesia in an adolescent patient.
• Lithium carbonate served as a viable alternative to neuroleptics for managing behavioral disturbances.
• Early recognition and appropriate management are crucial for pediatric TD.

Implications:

• This case underscores the need for vigilance regarding neuroleptic-induced tardive dyskinesia in young patients.
• Deanol may be a potential treatment option for pediatric tardive dyskinesia.
• Alternative medications like lithium carbonate can be considered for managing behavioral issues, potentially reducing neuroleptic exposure.